by Andreu Prados
Fecal microbiota transplantation (FMT) has shown to be efficient in recurrent Clostridioides difficile infection and is being researched in clinical trials for other conditions, but its mechanisms of action remain poorly understood. Two new studies shed light on factors that predict clinical success in FMT.
by GMFH Editing Team
Significant strides have been made in our comprehension of the role of the gut microbiome in health and disease throughout the year 2022. We invite you to take a closer look at the "2022 Year at a Glance" report and learn about the groundbreaking discoveries made.
by Andreu Prados
While fecal microbiota transplants are recommended for multiple recurrent Clostridioides difficile infection, their use in clinical practice is hindered by a lack of regulation and understanding of the underlying ecological dynamics. This article covers major challenges for the treatment in transitioning from bench to bedside, from the scientific, clinical and regulatory perspectives (Part 6).
by Konstantina Zafeiropoulou
Just one month before friends and families gather around the Christmas table, November is here to bring awareness around Clostridioides difficile infection, and the importance of microbiota-derived treatments. With this post, all of us in GMFH aim to highlight the importance of protecting ourselves and families and stopping the spread of this potentially deadly infection.
by GMFH Editing Team
Fecal microbiota transplantation is being studied in the context of metabolic health, beyond its use for recurrent Clostridioides difficile infection. A new proof-of-principle study reveals that supplementing low-fermentable fiber following fecal microbiota transplantation may improve insulin sensitivity in individuals with severe obesity.
by Andreu Prados
The microbiota of infants born by caesarean section resembles that of maternal oral cavity and skin, whereas that of vaginally born infants resembles that of the maternal gut microbiome. A new proof-of-concept study shows that the gut microbiota of C-section-born infants can be restored after delivery via orally administered maternal fecal microbiota transplantation.
by Andreu Prados
An altered balance of the community of microbes that reside in our body, especially within the gut, has been linked to a wide range of intestinal and extraintestinal diseases. What evidence-based strategies are currently available for modulating the gut microbiota?
by Stéphane Schneider
The benefits of fecal microbiota transplantation in treating Clostridioides difficile infection are well documented. Despite this, a new study concerns the transfer of extended-spectrum beta-lactamase-producing Escherichia coli in two immunocompromised adults.
by Paul Enck
this is the first study that has simultaneously studied the impact of FMT on IBS symptoms and changes in the gut microbiota's composition.
